MAP1LC3A and breast carcinoma: Thus, low levels of cytoplasmic Kaiso combined with low levels of the autophagy-related factor LC3A/B, predict favorable survival in breast cancer patients with TNBC, implicating a significant role for this biomarker in tumor progression and survival.